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ABSTRACT
A monoclonal antibody to an antigen (EBA) expressed by neural endothelial cells (EC) was used to
investigate any difference in the distribution of EBA between the CNS and PNS. Pre-embedding
ultrastructural cytochemistry of rat sciatic and optic nerves was undertaken using anti-EBA, detected with a
silver-enhanced gold-conjugated secondary antibody. LM immunocytochemical localisation of EBA was also
performed using an HRP-conjugated secondary antibody. EC of pial and parenchymal optic nerve vessels
were strongly immunopositive for EBA. Vessels of the dura were negative. At the EM level EBA was
observed on the EC luminal surface. In contrast, EC of sciatic nerve were either negative or only weakly
immunopositive. The molecular characteristics and function of EBA are largely unknown. Therefore the
functional significance of the present findings remains to be determined.
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INTRODUCTION
A mouse monoclonal antibody (IgGi) raised by
immunisation with an homogenate of rat brain has
been shown to react with endothelial cells (EC) in the
rat nervous system (Sternberger & Sternberger, 1987).
Since the antibody binding was evident in EC with
highly selective barrier properties, the antibody was
named anti-endothelial-barrier antigen (anti-EBA). In
CNS regions lacking a blood-brain barrier (BBB),
where fenestrated vessels are present, as in the area
postrema, microvessels were only weakly reactive or
nonreactive. The antibody did not react with neurons
or glial cells. It was absent from EC at embryonic d 18
(Rosenstein et al. 1992) but present as early as 3 d post
partum (Sternberger & Sternberger, 1987). Blood
vessels in other organs, including heart, muscle,
intestine and liver, were negative for anti-EBA
(Sternberger & Sternberger, 1987). Following stab
wound injury to the rat brain, EC of affected
microvessels failed to show anti-EBA reactivity
concurrent with a loss of BBB properties, with
reactivity returning to normal by 3-4 wk (Rosenstein
et al. 1992). Similarly transplants of fetal cortex into
adult rat brain lacked EBA expression in EC at 2 wk,
but were immunopositive by 4 wk (Rosenstein et al.
1992). In lesions of experimental allergic encephalo-
myelitis (EAE) microvessels surrounded by inflam-
matory cells lacked anti-EBA reactivity which was re-
expressed as the lesions resolved (Sternberger et al.
1989). In aged rats EBA-positive microvessels were
significantly reduced in number in the hippocampus
but not in other cerebral cortical areas (Mooradian et
al. 1993).
The molecular composition and structure of EBA
are little understood while its function is unknown. It
consists of a protein triplet of 23.5, 25 and 30 kDa as
shown by immunoblots prepared from rat brain
microvessels (Stemberger & Sternberger, 1987). The
only indication of its possible function is derived from
its restricted morphological distribution (Sternberger
& Stemberger, 1987). To clarify its distribution
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Fig. 1. Longitudinal section of optic nerve showing parenchymal
microvessels which are immunopositive for EBA (arrows). Lightly
counterstained with haematoxylin. x 430.
further, its presence in the CNS and PNS was
compared. An ultrastructural study was undertaken
employing the silver-enhanced gold-conjugated anti-
body technique.
MATERIALS AND METHODS
Twelve Sprague-Dawley male rats (200-300 g) were
anaesthetised with i.m. Hypnorm (0.16 mg/kg body
weight) following sedation with i.p. diazepam (0.2 mg/
kg body weight). Vascular perfusion was initially with
Dulbecco's phosphate-buffered saline (DPBS: pH 7.3,
320 mOsm at 37 °C) supplemented with minimum
essential medium and gassed with 95% 02:5% CO2.
This was followed with phosphate-buffered 0.2%
Fig. 2. Transverse section of optic nerve in dark field illumination.
Both parenchymal (single arrows) and pial (double arrows) vessels
are strongly EBA-positive. x 340.
glutaraldehyde-2 % paraformaldehyde fixative
(pH 7.3 at 4 °C) for 10 min. Sciatic nerves, optic
nerves and eyes were removed and immersed in the
same fixative for 2 h.
For ultrastructural cytochemistry, Vibratome sec-
tions (200 gm) of optic and sciatic nerves were
incubated in the primary antibody (Sternberger &
Sternberger, 1987): anti-EBA (mouse monoclonal
antirat, diluted 1:100 in 50 mM-TBS, pH 7.6, con-
taining 1 % normal goat serum, overnight; obtained
from Affiniti Research Products Ltd, Nottingham,
UK). The sections were washed in TBS and incubated
in the secondary antibody (1 nm gold-conjugated goat
antimouse IgG, diluted 1: 50 in 20 mM-TBS, pH 7.0
for 3 h; obtained from Affiniti). As controls the
primary antibody was omitted. After washing in
Fig. 3. Immunogold labelling of EC for EBA (silver-enhanced). (A) Parenchymal vessel from optic nerve showing heavy labelling with gold
particles (arrows) on the luminal plasmalemma. x 45000. (B) Endoneurial vessel from sciatic nerve showing sparse labelling (arrows) of the
luminal plasmalemma. x 22500. The variation in size and shape of the particles is a feature of the silver enhancement technique and has
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Fig. 3. For legend see opposite.
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buffer, the gold-antibody conjugate was silver en-
hanced using a BioCell kit (Cardiff, UK) for 10 min.
After further washing, the sections were osmicated
(1 % OS04 solution for 60 min), dehydrated (graded
ethanols) and embedded in epoxy resin (EM labora-
tories Ltd, Reading, UK). Conventional ultrathin
sections were examined by electron microscopy.
For light microscopical cytochemistry, segments of
the sciatic nerve and the posterior part of the eye were
processed conventionally for paraffin wax embedding.
The sciatic nerve, optic nerve head and intraorbital
optic nerve were examined. Sections (8-10 jm) were
collected on glass slides precoated with poly-L-lysine,
dewaxed with xylene and transferred to absolute
alcohol. Sections were incubated for 10 min in normal
goat serum 1:10 in TBS. Endogenous peroxidase was
blocked with 0.5 % hydrogen peroxide in absolute
methanol for 30 min (sections of spleen, both blocked
and unblocked, were used as controls). After rinses in
distilled water and TBS, sections were incubated in
anti-EBA (diluted 1: 500 and 1: 1000 in 50 mM-TBS,
pH 7.6, overnight; Affiniti). Sections were incubated
after TBS rinses, with goat-antimouse horseradish
peroxidase (HRP) conjugate (1:100 in 20 mM-TBS
pH 7.0 for 3 h; obtained from Dako, High Wycombe,
UK). After TBS rinses, sections were exposed to 0.1 %
diaminobenzidine tetrahydrochloride (DAB) with
0.02% hydrogen peroxide for 2-5 min followed by
rinses in distilled and tap water. Sections were stained
with haematoxylin and conventionally mounted for
examination by light microscopy (LM).
RESULTS
Optic nerve, examined by LM (Figs 1,2), showed
immunopositive vessels in the parenchyma and pia
while vessels in the dura were negative. Capillaries
were more strongly labelled with HRP than arterioles
and venules. Electron microscopy (EM) confirmed
that labelling was confined to pial and parenchymal
vessels. Gold particles were numerous along the
luminal membrane of the EC in tissue treated with the
gold-antibody conjugate (Fig. 3 A). Although the
nature of the pre-embedding labelling technique
limited antibody access to the EC cytoplasm and
abluminal surface, there was no evidence of labelling
in these areas in EC at the Vibratome faces which had
unrestricted exposure to antibodies. Controls were
negative.
Sciatic nerve examined by LM (paraffin wax
sections) showed no labelling in epineurial, perineurial
or endoneurial vessels. By using polyester wax as the
DAB, weak immunoreactivity was obtained but in
only a minority of endoneurial vessels. By EM
epineurial and perineurial vessels were seen to be
unlabelled. Endoneurial vessels were also mostly
EBA-negative, but in a minority of vessels there was
sparse labelling (Fig. 3B) though even here large
segments of the luminal surface were free of gold
labelling. The control tissues were unreactive for
EBA.
DISCUSSION
This study demonstrates a heterogeneity in EC within
the nervous system, even between vessels showing
barrier properties. It has previously been shown that
EBA immunoreactivity is absent or reduced from
fenestrated vessels which occur in normal CNS regions
lacking a BBB (Stemberger & Sternberger, 1987),
from microvessels in EAE lesions (Sternberger et al.
1989) and from some microvessels in the aged
hippocampus (Mooradian et al. 1993). We have shown
in this study by both LM and EM immunocyto-
chemistry that parenchymal vessels in the optic nerve
are highly reactive for EBA while endoneurial vessels
of the sciatic nerve are unreactive or only slightly
reactive. This appears not to have been demonstrated
previously and contrasts with the observation of
Sternberger & Stemberger (1987) that EC in the PNS
expressed EBA. These workers did not state the PNS
site examined and it is possible that a degree of
heterogeneity exists within the PNS. This may relate
to differences between nerves or to proximity to the
CNS.
Astrocytes play an important, though still ill-
defined, role both in inducing and maintaining BBB
properties in EC (Bradbury, 1993). However, the
absence of an astrocytic, or as yet unknown equiva-
lent, cellular role in maintaining blood-nerve barrier
function is unlikely to be a complete explanation for
the difference in EBA labelling, since EBA is absent
from EC in some -regions of the normal and
pathological CNS in both of which astrocytes are
present (Stemberger & Sternberger, 1987, 1989;
Rosenstein et al. 1992). In addition EBA reactivity
has also been described in some cells in the skin,
tentatively identified as Langerhans cells (Sternberger
& Sternberger, 1987), which are known to participate
in the presentation of antigen in association with
major histocompatibility complex (MHC) class II
molecules (Stemberger & Sternberger, 1987). How-
ever, it is unlikely that anti-EBA recognises MHC
class II antigens, which are not expressed on EC of the
normal CNS (Welsh et al. 1993). Furthermore theembedding medium and a long exposure (10 min) to
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evidence for EC of the normal CNS acting as antigen
presenting cells is now considered insubstantial (Male,
1992). Antibody binding to transferrin receptor has
been demonstrated in brain EC and it has been
proposed that EBA might be a cell surface receptor
(Sternberger et al. 1989). However, the absence of
EBA from most EC outside the nervous system,
together with its presence on Langerhans cells, makes
the transport receptor hypothesis difficult to interpret.
Anti-EBA is one of 5 monoclonal (mAb) antibodies
(reviewed by Dermietzel & Krause, 1991) which show
BBB specificity. Anti-EBA is apparently distinct from
3 of these which also bind to EC at the BBB while the
fourth is immunoreactive to an antigen of the pericyte
plasmalemma. An mAb, termed HT7, with an MW of
74 kDa, has been shown to react specifically with
chick EC at the BBB plus a plasmalemmal antigen of
embryonic blood cells. A mouse mAb, 1W5, which
recognises neurothelin (A 43 kDa glycoprotein) at the
BBB has also been described. Neurothelin is present
not only on EC but also on other neural tissue and
some neuroepithelial derivatives. A further mAb
appears to be distinct. It labels EC cytoplasm, luminal
membranes and an extracellular layer at the rat BBB
but its molecular characteristics are not known. Anti-
EBA is exceptional in that other BBB-specific mono-
clonal (and polyclonal) antibodies also react with at
least one of the class of transporting epithelia
(Dermietzel & Krause, 1991). The functional signifi-
cance of this difference remains to be elucidated.
REFERENCES
BRADBURY MWB (1993) The blood-brain barrier. Experimental
Physiology 78, 453-472.
DERMIETZEL R, KRAUSE D (1991) Molecular anatomy of the
blood-brain barrier as defined by immunocytochemistry. In-
ternational Review of Cytology 127, 57-109.
MALE DK (1992) Immunology of the brain endothelium and the
blood-brain barrier. In Physiology and Pharmacology of the
Blood-Brain Barrier, Handbook of Experimental Pharmacology,
vol 103 (ed. M. W. B. Bradbury), pp. 397-415. Berlin: Springer.
MOORADIAN AD, GRABAU G, UKO-ENINN A (1993) In situ
quantitative estimates of the age-related and diabetes-related
changes in cerebral endothelial barrier antigen. Brain Research
609, 41-44.
ROSENSTEIN JM, KRUM JM, STERNBERGER LA, PULLEY MT,
STERNBERGER NH (1992) Immunocytochemical expression of the
endothelial barrier antigen (EBA) during brain angiogenesis.
Developmental Brain Research 66, 47-54.
STERNBERGER NH, STERNBERGER LA (1987) Blood-brain barrier
protein recognized by monoclonal antibody. Proceedings of the
National Academy of Sciences of the USA 84, 8169-8173.
STERNBERGER NH, STERNBERGER LA, KEEs NW, SBEAR CR (1989)
Cell surface endothelial proteins altered in experimental allergic
encephalomyelitis. Journal of Neuroimmunology 21, 241-248.
WELSH J, SAPATINO B, ROSENBAUM B, SMITH R, LINTHICUM S
(1993) Correlation between susceptibility to demyelination and
interferon-y induction of major histocompatibility complex class
II antigens on murine cerebrovascular endothelial cells. Journal
of Neuroimmunology 48, 91-98.
